Cargando…
The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trial
OBJECTIVE: To study the effects of long-term oral benfotiamine supplementation on peripheral nerve function and soluble inflammatory markers in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: The study randomly assigned 67 patients with type 1 diabetes to receive 24-month benfotiamine (3...
Autores principales: | Fraser, David A., Diep, Lien M., Hovden, Inger Anette, Nilsen, Kristian B., Sveen, Kari Anne, Seljeflot, Ingebjørg, Hanssen, Kristian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329837/ https://www.ncbi.nlm.nih.gov/pubmed/22446172 http://dx.doi.org/10.2337/dc11-1895 |
Ejemplares similares
-
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
por: Fraser, David A., et al.
Publicado: (2012) -
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
por: Holte, Kristine B., et al.
Publicado: (2020) -
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010) -
Thiamine and benfotiamine: Focus on their therapeutic potential
por: Bozic, Iva, et al.
Publicado: (2023) -
Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
por: Ziegler, Dan, et al.
Publicado: (2012)